Patent details

EP4147053 Title: ANTXR1 AS A BIOMARKER OF IMMUNOSUPPRESSIVE FIBROBLAST POPULATIONS AND ITS USE FOR PREDICTING RESPONSE TO IMMUNOTHERAPY

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
17/02/2026
Unitary Effect Status:
Unitary Effect Registered
Request Unitary Effect Accepted:
23/02/2026
Unitary Effect Date:
28/01/2026
Unitary Effect Registration Date:
23/02/2026
Request Unitary Effect Rejected:
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Unitary Effect Request Withdrawal Date:
Unitary Effect request has been accepted, please see the UPP register at the EPO for up-to-date information
UPP register:
EP4147053
SPC Number:
Creation Date:

Basic Information

Publication number:
EP4147053
WO Application Number:
EP2021062090
Type:
European Patent Granted for NL
Status:
Unitary Effect Registered
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP21723277.6
WO Publication Number:
WO2021224438
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
France (FR)
Publications:

Dates

Filing date:
07/05/2021
Grant date:
28/01/2026
EP Publication Date:
15/03/2023
WO Publication Date:
11/11/2021
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
28/01/2026
EP B1 Publication Date:
28/01/2026
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
06/05/2041
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
28/01/2026
 
 

 

Name:
Institut Curie
Address:
26, rue d'Ulm, 75248 PARIS CEDEX 05, France (FR)

From:
28/01/2026
 
 

 

Name:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Address:
101 rue de Tolbiac, 75013 Paris, France (FR)

Inventor

1

Name:
MECHTA-GRIGORIOU, Fatima
Address:
94100 SAINT MAUR DES FOSSES, France (FR)

2

Name:
KIEFFER, Yann
Address:
94700 MAISONS-ALFORT, France (FR)

3

Name:
VINCENT-SALOMON, Anne
Address:
75013 PARIS, France (FR)

4

Name:
HOCINE, Rachid, Hocine
Address:
MANHATTAN, NEW YORK 10021, United States of America (US)

Priority

Priority Patent Number:
20305454
Priority Date:
07/05/2020
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC or IDT classification:
G01N 33/574; C07K 16/00;

Publication

Bulletin

1

Bulletin Heading:
UP1
Journal edition number:
12/26
Publication date:
25/03/2026
Description:
European patents with registered Unitary Effect

2

Bulletin Heading:
EP2
Journal edition number:
04/26
Publication date:
28/01/2026
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202613
Publication date:
25/03/2026
Description:
Unitary Effect Request Receipt

2

Issue number:
202613
Publication date:
25/03/2026
Description:
Unitary Effect Request Acceptance

3

Issue number:
202605
Publication date:
28/01/2026
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type